← Back to Search

Virtual Reality vs. Video Chat for Improving Quality of Life in Seniors (Thrive Trial)

N/A
Waitlist Available
Led By Tamara Afifi, PhD
Research Sponsored by University of California, Santa Barbara
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
at least 50 years old
fluent in English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (1-week pre-intervention), 1-week post-intervention, 1-month post-intervention, 3-months post-intervention
Awards & highlights

Thrive Trial Summary

This trial is testing whether virtual reality or video chat can improve the quality of life for older adults in senior living communities, and whether it matters if they have cognitive impairments.

Who is the study for?
This study is for older adults over 50 living in one of the participating senior communities and their adult children who live at least 45 minutes away. Participants must be fluent in English or Spanish. It aims to help those dealing with dementia, caregiver stress, and related mental health issues.Check my eligibility
What is being tested?
The trial is examining how virtual reality and video chat technologies affect quality of life, family connections, and feelings of loneliness among seniors and their distant adult children. It also looks at how cognitive impairment levels might influence these outcomes.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort or dizziness from virtual reality use for some individuals; emotional distress could arise from discussing personal topics during video chats.

Thrive Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 50 years old.
Select...
I am fluent in English or Spanish.
Select...
I am at least 18 years old.
Select...
I am fluent in either English or Spanish.

Thrive Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (1-week pre-intervention), 1-week post-intervention, 1-month post-intervention, 3-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (1-week pre-intervention), 1-week post-intervention, 1-month post-intervention, 3-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Inventory of Thriving (BIT) - changes from Baseline
Caregiver Guilt and Grief Scale - changes from Baseline
Center for Epidemiological Studies Depression Scale Revised Short Form (CESD-R-10) - changes from Baseline
+10 more
Secondary outcome measures
Positive and Negative Affect Schedule (PANAS)
Relationship satisfaction and Communication Quality
Social and Conversational Engagement
+1 more

Thrive Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual RealityExperimental Treatment1 Intervention
Weekly activities using virtual reality (Rendever)
Group II: Video ChatActive Control1 Intervention
Weekly activities using video conference (Zoom)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
2017
Completed Phase 3
~1630

Find a Location

Who is running the clinical trial?

University of California, Santa BarbaraLead Sponsor
28 Previous Clinical Trials
2,633 Total Patients Enrolled
Rendever, Inc.UNKNOWN
Tamara Afifi, PhDPrincipal InvestigatorUniversity of California, Santa Barbara

Media Library

Virtual Reality Clinical Trial Eligibility Overview. Trial Name: NCT05150990 — N/A
Dementia Research Study Groups: Video Chat, Virtual Reality
Dementia Clinical Trial 2023: Virtual Reality Highlights & Side Effects. Trial Name: NCT05150990 — N/A
Virtual Reality 2023 Treatment Timeline for Medical Study. Trial Name: NCT05150990 — N/A
Dementia Patient Testimony for trial: Trial Name: NCT05150990 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the estimated recruitment number of participants for this research study?

"Affirmative. According to the information on clinicaltrials.gov, recruitment for this trial is in progress and has been since October 12th 2021. The study was last updated November 26th 2021; it seeks 384 participants from 2 separate locations."

Answered by AI

Can you explain the central aims of this trial?

"The primary aim of this trial is to observe the transformation in relationship satisfaction from Baseline (1-week Pre-intervention) to 1-week Post-intervention, 1-month Post-intervention and 3 months post intervention. Secondary objectives include garnering insight into Relationship Satisfaction, Communication Quality, Telepresence/Copresence with Positive Affect Schedule (PANAS). Scores will be tabulated over four weeks for an overall score across these variables."

Answered by AI

Are researchers still enrolling participants in this experiment?

"A quick perusal of clinicaltrials.gov reveals that this medical trial is actively enlisting participants, with the initial posting on December 10th 2021 and most recent edit made November 26th 2021."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Oakmont of Camarillo
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Would like to be part of something that could help others.
PatientReceived 2+ prior treatments
~109 spots leftby Mar 2025